Inflammatory disequilibrium in stroke

Circulation Research

Volumn 119, Issue 1, 2016, Pages 142-158

  Petrovic Djergovic, Danica ^a   Goonewardena, Sascha N ^a   Pinsky, David J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

adaptive immunity; blood brain barrier; brain ischemia; CD39; CD73; inflammation; innate immunity

Indexed keywords

COMPLEMENT;

ADAPTIVE IMMUNITY; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; COMPLEMENT ACTIVATION; CONCEPTUAL FRAMEWORK; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MAST CELL; MICROGLIA; NEUROPATHOLOGY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; ANIMAL; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

ADAPTIVE IMMUNITY; ANIMALS; BLOOD-BRAIN BARRIER; HUMANS; IMMUNITY, INNATE; NEUROIMMUNOMODULATION; STROKE;

EID: 84975885927     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.308022     Document Type: Review

References (170)

1. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA, Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000 283 1145 1150
2. Lees KR, Bluhmki E, von Kummer R, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010 375 1695 1703. doi: 10.1016/S0140-6736(10)60491-6
3. Zhang RL, Chopp M, Li Y, Zaloga C, Jiang N, Jones ML, Miyasaka M, Ward PA, Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 1994 44 1747 1751
4. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab acute stroke trial. Neurology 2001 57 1428 1434
5. Vuorte J, Lindsberg PJ, Kaste M, Meri S, Jansson SE, Rothlein R, Repo H, Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 1999 162 2353 2357
6. Chen Y, Ruetzler C, Pandipati S, Spatz M, McCarron RM, Becker K, Hallenbeck JM, Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc Natl Acad Sci U S A 2003 100 15107 15112. doi: 10.1073/pnas.2436538100
7. Ishibashi S, Maric D, Mou Y, Ohtani R, Ruetzler C, Hallenbeck JM, Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab 2009 29 606 620. doi: 10.1038/jcbfm.2008.153
8. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA, Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 2003 140 471 476. doi: 10.1038/sj.bjp.0705462
9. Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N, Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 2002 22 38 43
10. Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ, Acute Stroke Investigators A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 2005 76 1366 1372. doi: 10.1136/jnnp.2004.054882
11. Schäbitz WR, Dirnagl U, Are we ready to translate T-cell transmigration in stroke? Stroke 2014 45 1610 1611. doi: 10.1161/STROKEAHA.114.005294
12. Liesz A, Zhou W, Mracskó É Karcher S, Bauer H, Schwarting S, Sun L, Bruder D, Stegemann S, Cerwenka A, Sommer C, Dalpke AH, Veltkamp R, Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 2011 134 704 720. doi: 10.1093/brain/awr008
13. Langhauser F, Kraft P, Göb E, Leinweber J, Schuhmann MK, Lorenz K, Gelderblom M, Bittner S, Meuth SG, Wiendl H, Magnus T, Kleinschnitz C, Blocking of α4 integrin does not protect from acute ischemic stroke in mice. Stroke 2014 45 1799 1806. doi: 10.1161/STROKEAHA.114.005000
14. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G, Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007 115 2323 2330. doi: 10.1161/CIRCULATIONAHA.107.691279
15. Adams HP Jr, Effron MB, Torner J, Dávalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, Hacke W, AbESTT-II Investigators Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008 39 87 99. doi: 10.1161/STROKEAHA.106.476648
16. Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan PH, Koistinaho J, A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999 96 13496 13500
17. Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A, Hess DC, Minocycline to improve neurologic outcome in stroke (MINOS): A dose-finding study. Stroke 2010 41 2283 2287. doi: 10.1161/STROKEAHA.110.582601
18. Tang XN, Wang Q, Koike MA, Cheng D, Goris ML, Blankenberg FG, Yenari MA, Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia. J Nucl Med 2007 48 1822 1828. doi: 10.2967/jnumed.107.041335
19. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C, Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 2011 69 119 129. doi: 10.1002/ana.22186
20. Fu Y, Zhang N, Ren L, Yan Y, Sun N, Li YJ, Han W, Xue R, Liu Q, Hao J, Yu C, Shi FD, Impact of an immune modulator fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S A 2014 111 18315 18320. doi: 10.1073/pnas.1416166111
21. Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS, Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proc Natl Acad Sci U S A 2012 109 15930 15935. doi: 10.1073/pnas.1203534109
22. Budde K, Schmouder RL, Brunkhorst R, Nashan B, Lücker PW, Mayer T, Choudhury S, Skerjanec A, Kraus G, Neumayer HH, First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002 13 1073 1083
23. Zhu Z, Fu Y, Tian D, Sun N, Han W, Chang G, Dong Y, Xu X, Liu Q, Huang D, Shi FD, Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial. Circulation 2015 132 1104 1112. doi: 10.1161/CIRCULATIONAHA.115.016371
24. Gibson CL, Bath PM, Murphy SP, G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005 25 431 439. doi: 10.1038/sj.jcbfm.9600033
25. Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A, AXIS: A trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke 2010 41 2545 2551. doi: 10.1161/STROKEAHA.110.579508
26. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K, Takagi S, Okano H, Ando K, Hotta T, Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 2006 113 701 710. doi: 10.1161/CIRCULATIONAHA.105.563668
27. Ringelstein EB, Thijs V, Norrving B, AXIS 2 Investigators Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke 2013 44 2681 2687. doi: 10.1161/STROKEAHA.113.001531
28. Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, Li H, Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004 110 1847 1854. doi: 10.1161/01.CIR.0000142616.07367.66
29. Schneider A, Krüger C, Steigleder T, The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005 115 2083 2098. doi: 10.1172/JCI23559
30. Liu X, Ye R, Yan T, Yu SP, Wei L, Xu G, Fan X, Jiang Y, Stetler RA, Liu G, Chen J, Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol 2014 115 92 115. doi: 10.1016/j.pneurobio.2013.11.007
31. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, Jametti LP, Kilic E, Kilic U, Salani G, Brambilla E, West MJ, Comi G, Martino G, Hermann DM, Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009 132 2239 2251. doi: 10.1093/brain/awp174
32. Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Piñero P, Espigado I, Garcia-Solis D, Cayuela A, Montaner J, Boada C, Rosell A, Jimenez MD, Mayol A, Gil-Peralta A, Intra-Arterial bone marrow mononuclear cells in ischemic stroke: A pilot clinical trial. Stroke 2012 43 2242 2244. doi: 10.1161/STROKEAHA.112.659409
33. Chen J, Shehadah A, Pal A, Zacharek A, Cui X, Cui Y, Roberts C, Lu M, Zeitlin A, Hariri R, Chopp M, Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplant 2013 22 871 879. doi: 10.3727/096368911X637380
34. Roitberg BZ, Mangubat E, Chen EY, Sugaya K, Thulborn KR, Kordower JH, Pawar A, Konecny T, Emborg ME, Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J Neurosurg 2006 105 96 102. doi: 10.3171/jns.2006.105.1.96
35. Libby P, Mechanisms of acute coronary syndromes. N Engl J Med 2013 369 883 884. doi: 10.1056/NEJMc1307806
36. Marder VJ, Chute DJ, Starkman S, Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006 37 2086 2093. doi: 10.1161/01.STR.0000230307.03438.94
37. Fu Y, Liu Q, Anrather J, Shi FD, Immune interventions in stroke. Nat Rev Neurol 2015 11 524 535. doi: 10.1038/nrneurol.2015.144
38. Hagberg H, Mallard C, Ferriero DM, Vannucci SJ, Levison SW, Vexler ZS, Gressens P, The role of inflammation in perinatal brain injury. Nat Rev Neurol 2015 11 192 208. doi: 10.1038/nrneurol.2015.13
39. Jin R, Yang G, Li G, Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010 87 779 789. doi: 10.1189/jlb.1109766
40. Shechter R, Schwartz M, Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J Pathol 2013 229 332 346. doi: 10.1002/path.4106
41. Engelhardt B, Sorokin L, The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 2009 31 497 511. doi: 10.1007/s00281-009-0177-0
42. Ransohoff RM, Brown MA, Innate immunity in the central nervous system. J Clin Invest 2012 122 1164 1171. doi: 10.1172/JCI58644
43. Russo MV, McGavern DB, Immune Surveillance of the CNS following Infection and Injury. Trends Immunol 2015 36 637 650. doi: 10.1016/j.it.2015.08.002
44. Wilson EH, Weninger W, Hunter CA, Trafficking of immune cells in the central nervous system. J Clin Invest 2010 120 1368 1379. doi: 10.1172/JCI41911
45. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J, Structural and functional features of central nervous system lymphatic vessels. Nature 2015 523 337 341. doi: 10.1038/nature14432
46. Chen GY, Nuñez G, Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010 10 826 837. doi: 10.1038/nri2873
47. Ransohoff RM, Kivisäkk P, Kidd G, Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003 3 569 581. doi: 10.1038/nri1130
48. Shechter R, London A, Schwartz M, Orchestrated leukocyte recruitment to immune-privileged sites: Absolute barriers versus educational gates. Nat Rev Immunol 2013 13 206 218. doi: 10.1038/nri3391
49. Engelhardt B, Ransohoff RM, Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol 2012 33 579 589. doi: 10.1016/j.it.2012.07.004
50. Krueger M, Bechmann I, CNS pericytes: concepts, misconceptions, and a way out. Glia 2010 58 1 10. doi: 10.1002/glia.20898
51. Iadecola C, Astrocytes take center stage in salt sensing. Neuron 2007 54 3 5. doi: 10.1016/j.neuron.2007.03.013
52. Troletti CD, De Goede P, Kamermans A, De Vries HE, Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition. Biochim Biophys Acta 2016 1862 452 460. doi: 10.1016/j.bbadis.2015.10.010
53. Abbott NJ, Rönnbäck L, Hansson E, Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006 7 41 53. doi: 10.1038/nrn1824
54. Rubin LL, Staddon JM, The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999 22 11 28. doi: 10.1146/annurev.neuro.22.1.11
55. Sonobe Y, Takeuchi H, Kataoka K, Li H, Jin S, Mimuro M, Hashizume Y, Sano Y, Kanda T, Mizuno T, Suzumura A, Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner. J Biol Chem 2009 284 31834 31842. doi: 10.1074/jbc.M109.025940
56. Cruz-Orengo L, Chen YJ, Kim JH, Dorsey D, Song SK, Klein RS, CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity. J Neuroinflammation 2011 8 170. doi: 10.1186/1742-2094-8-170
57. Jin AY, Tuor UI, Rushforth D, Kaur J, Muller RN, Petterson JL, Boutry S, Barber PA, Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: A future therapeutic target for treatment of stroke. BMC Neurosci 2010 11 12. doi: 10.1186/1471-2202-11-12
58. Engblom D, Ek M, Saha S, Ericsson-Dahlstrand A, Jakobsson PJ, Blomqvist A, Prostaglandins as inflammatory messengers across the blood-brain barrier. J Mol Med (Berl) 2002 80 5 15. doi: 10.1007/s00109-001-0289-z
59. Huang J, Upadhyay UM, Tamargo RJ, Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006 66 232 245. doi: 10.1016/j.surneu.2005.12.028
60. Yilmaz G, Granger DN, Cell adhesion molecules and ischemic stroke. Neurol Res 2008 30 783 793. doi: 10.1179/174313208X341085
61. Yilmaz G, Granger DN, Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 2010 12 193 204. doi: 10.1007/s12017-009-8074-1
62. Yang Y, Rosenberg GA, Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 2011 42 3323 3328. doi: 10.1161/STROKEAHA.110.608257
63. Cuadrado E, Ortega L, Hernández-Guillamon M, Penalba A, Fernández-Cadenas I, Rosell A, Montaner J, Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release. J Leukoc Biol 2008 84 207 214. doi: 10.1189/jlb.0907606
64. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH, Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005 36 1954 1959. doi: 10.1161/01.STR.0000177517.01203.eb
65. Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS, Fiebich BL, Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 2007 100 1108 1120. doi: 10.1111/j.1471-4159.2006.04280.x
66. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C, Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 2006 12 225 229. doi: 10.1038/nm1362
67. Zador Z, Bloch O, Yao X, Manley GT, Aquaporins: role in cerebral edema and brain water balance. Prog Brain Res 2007 161 185 194. doi: 10.1016/S0079-6123(06)61012-1
68. Connolly ES Jr, Winfree CJ, Prestigiacomo CJ, Kim SC, Choudhri TF, Hoh BL, Naka Y, Solomon RA, Pinsky DJ, Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res 1997 81 304 310
69. Huang J, Choudhri TF, Winfree CJ, McTaggart RA, Kiss S, Mocco J, Kim LJ, Protopsaltis TS, Zhang Y, Pinsky DJ, Connolly ES Jr, Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke 2000 31 3047 3053
70. Mocco J, Choudhri T, Huang J, Harfeldt E, Efros L, Klingbeil C, Vexler V, Hall W, Zhang Y, Mack W, Popilskis S, Pinsky DJ, Connolly ES Jr, HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ Res 2002 91 907 914
71. Connolly ES Jr, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stern DM, Solomon RA, Gutierrez-Ramos JC, Pinsky DJ, Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 1996 97 209 216. doi: 10.1172/JCI118392
72. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, Hori M, Matsumoto M, Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 2000 31 1735 1743
73. Iadecola C, Anrather J, The immunology of stroke: from mechanisms to translation. Nat Med 2011 17 796 808. doi: 10.1038/nm.2399
74. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D, Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 2011 10 471 480. doi: 10.1016/S1474-4422(11)70066-7
75. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, Rolls A, Mack M, Pluchino S, Martino G, Jung S, Schwartz M, Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009 6 e1000113. doi: 10.1371/journal.pmed.1000113
76. Shechter R, Miller O, Yovel G, Rosenzweig N, London A, Ruckh J, Kim KW, Klein E, Kalchenko V, Bendel P, Lira SA, Jung S, Schwartz M, Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013 38 555 569. doi: 10.1016/j.immuni.2013.02.012
77. Huang J, Kim LJ, Mealey R, Marsh HC Jr, Zhang Y, Tenner AJ, Connolly ES Jr, Pinsky DJ, Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999 285 595 599
78. Ten VS, Sosunov SA, Mazer SP, Stark RI, Caspersen C, Sughrue ME, Botto M, Connolly ES Jr, Pinsky DJ, C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 2005 36 2244 2250. doi: 10.1161/01.STR.0000182237.20807.d0
79. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG, Nair MN, Laufer I, Komotar RJ, Claire M, Holland H, Pinsky DJ, Connolly ES Jr, Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 2006 99 209 217. doi: 10.1161/01.RES.0000232544.90675.42
80. Levi M, Van Der Poll T, Büller HR, Bidirectional relation between inflammation and coagulation. Circulation 2004 109 2698 2704. doi: 10.1161/01.CIR.0000131660.51520.9A
81. Carvalho-Tavares J, Hickey MJ, Hutchison J, Michaud J, Sutcliffe IT, Kubes P, A role for platelets and endothelial selectins in tumor necrosis factor-Alpha-induced leukocyte recruitment in the brain microvasculature. Circ Res 2000 87 1141 1148
82. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998 391 591 594. doi: 10.1038/35393
83. Massberg S, Brand K, Grüner S, Page S, Müller E, Müller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M, A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002 196 887 896
84. Thornton P, McColl BW, Greenhalgh A, Denes A, Allan SM, Rothwell NJ, Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 2010 115 3632 3639. doi: 10.1182/blood-2009-11-252643
85. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M, Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010 330 841 845. doi: 10.1126/science.1194637
86. Ma Y, Wang J, Wang Y, Yang GY, The biphasic function of microglia in ischemic stroke [published online ahead of print February 2, 2016]. Prog Neurobiol. doi: 10.1016/j.pneurobio.2016.01.005. http://www.sciencedirect.com/science/article/pii/S0301008215300708
87. Kigerl KA, De Rivero Vaccari JP, Dietrich WD, Popovich PG, Keane RW, Pattern recognition receptors and central nervous system repair. Exp Neurol 2014 258 5 16. doi: 10.1016/j.expneurol.2014.01.001
88. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A, Physiology of microglia. Physiol Rev 2011 91 461 553. doi: 10.1152/physrev.00011.2010
89. Butovsky O, Jedrychowski MP, Moore CS, Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci 2014 17 131 143. doi: 10.1038/nn.3599
90. Block ML, Zecca L, Hong JS, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007 8 57 69. doi: 10.1038/nrn2038
91. London A, Cohen M, Schwartz M, Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci 2013 7 34. doi: 10.3389/fncel.2013.00034
92. Moskowitz MA, Lo EH, Iadecola C, The science of stroke: mechanisms in search of treatments. Neuron 2010 67 181 198. doi: 10.1016/j.neuron.2010.07.002
93. Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni MG, The ischemic environment drives microglia and macrophage function. Front Neurol 2015 6 81. doi: 10.3389/fneur.2015.00081
94. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F, A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012 336 86 90. doi: 10.1126/science.1219179
95. Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL, Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 2012 122 3063 3087. doi: 10.1172/JCI62636
96. Hanisch UK, Kettenmann H, Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007 10 1387 1394. doi: 10.1038/nn1997
97. Petrovic-Djergovic D, Hyman MC, Ray JJ, Bouis D, Visovatti SH, Hayasaki T, Pinsky DJ, Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain. J Immunol 2012 188 2387 2398. doi: 10.4049/jimmunol.1003671
98. Yang Z, Zhao TZ, Zou YJ, Zhang JH, Feng H, Hypoxia Induces autophagic cell death through hypoxia-inducible factor 1α in microglia. PLoS One 2014 9 e96509. doi: 10.1371/journal.pone.0096509
99. Riboldi E, Porta C, Morlacchi S, Viola A, Mantovani A, Sica A, Hypoxia-mediated regulation of macrophage functions in pathophysiology. Int Immunol 2013 25 67 75. doi: 10.1093/intimm/dxs110
100. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB, ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005 8 752 758. doi: 10.1038/nn1472
101. Geissmann F, Jung S, Littman DR, Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003 19 71 82
102. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ, The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007 204 3037 3047. doi: 10.1084/jem.20070885
103. Hyman MC, Petrovic-Djergovic D, Visovatti SH, Liao H, Yanamadala S, Bouïs D, Su EJ, Lawrence DA, Broekman MJ, Marcus AJ, Pinsky DJ, Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 2009 119 1136 1149. doi: 10.1172/JCI36433
104. Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B, Valous N, Grabe N, Veltkamp R, Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol 2013 23 34 44. doi: 10.1111/j.1750-3639.2012.00614.x
105. Akopov SE, Simonian NA, Grigorian GS, Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996 27 1739 1743
106. Mantovani A, Cassatella MA, Costantini C, Jaillon S, Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011 11 519 531. doi: 10.1038/nri3024
107. Köhler A, De Filippo K, Hasenberg M, Van den Brandt C, Nye E, Hosking MP, Lane TE, Männ L, Ransohoff RM, Hauser AE, Winter O, Schraven B, Geiger H, Hogg N, Gunzer M, G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 2011 117 4349 4357. doi: 10.1182/blood-2010-09-308387
108. Veenstra M, Ransohoff RM, Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller? J Neuroimmunol 2012 246 1 9. doi: 10.1016/j.jneuroim.2012.02.016
109. Herz J, Sabellek P, Lane TE, Gunzer M, Hermann DM, Doeppner TR, Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice. Stroke 2015 46 2916 2925. doi: 10.1161/STROKEAHA.115.010620
110. Zheng Z, Yenari MA, Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res 2004 26 884 892. doi: 10.1179/016164104X2357
111. Garcia-Bonilla L, Racchumi G, Murphy M, Anrather J, Iadecola C, Endothelial CD36 contributes to postischemic brain injury by promoting neutrophil activation via CSF3. J Neurosci 2015 35 14783 14793. doi: 10.1523/JNEUROSCI.2980-15.2015
112. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM, Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991 22 1276 1283
113. Ritter LS, Orozco JA, Coull BM, McDonagh PF, Rosenblum WI, Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke 2000 31 1153 1161
114. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T, Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009 15 1031 1037. doi: 10.1038/nm.2022
115. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM, Lauritzen M, Attwell D, Capillary pericytes regulate cerebral blood flow in health and disease. Nature 2014 508 55 60. doi: 10.1038/nature13165
116. Amulic B, Hayes G, Neutrophil extracellular traps. Curr Biol 2011 21 R297 R298. doi: 10.1016/j.cub.2011.03.021
117. Prestigiacomo CJ, Kim SC, Connolly ES Jr, Liao H, Yan SF, Pinsky DJ, CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke 1999 30 1110 1117
118. Sladojevic N, Stamatovic SM, Keep RF, Grailer JJ, Sarma JV, Ward PA, Andjelkovic AV, Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury. Neurobiol Dis 2014 67 57 70. doi: 10.1016/j.nbd.2014.03.010
119. Becker KJ, Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke. Curr Med Res Opin 2002 18 suppl 2 s18 s22
120. Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A, Gelderblom M, Arumugam TV, Broughton BR, Drummond GR, Sobey CG, Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab 2014 34 450 459. doi: 10.1038/jcbfm.2013.217
121. Yilmaz A, Fuchs T, Dietel B, Altendorf R, Cicha I, Stumpf C, Schellinger PD, Blumcke I, Schwab S, Daniel WG, Garlichs CD, Kollmar R, Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain. Clin Sci (Lond) 2010 118 147 157
122. Kostulas N, Li HL, Xiao BG, Huang YM, Kostulas V, Link H, Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 2002 33 1129 1134
123. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T, Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009 40 1849 1857. doi: 10.1161/STROKEAHA.108.534503
124. Dietel B, Cicha I, Kallmünzer B, Tauchi M, Yilmaz A, Daniel WG, Schwab S, Garlichs CD, Kollmar R, Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke. Exp Neurol 2012 237 379 387. doi: 10.1016/j.expneurol.2012.06.019
125. Felger JC, Abe T, Kaunzner UW, Gottfried-Blackmore A, Gal-Toth J, McEwen BS, Iadecola C, Bulloch K, Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav Immun 2010 24 724 737. doi: 10.1016/j.bbi.2009.11.002
126. Galli SJ, Tsai M, Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 2010 40 1843 1851. doi: 10.1002/eji.201040559
127. Ribatti D, Crivellato E, The role of mast cell in tissue morphogenesis. Thymus, duodenum, and mammary gland as examples. Exp Cell Res 2016 341 105 109. doi: 10.1016/j.yexcr.2015.11.022
128. Sayed BA, Christy AL, Walker ME, Brown MA, Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: A role for neutrophil recruitment? J Immunol 2010 184 6891 6900. doi: 10.4049/jimmunol.1000126
129. Malaviya R, Ikeda T, Ross E, Abraham SN, Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-Alpha. Nature 1996 381 77 80. doi: 10.1038/381077a0
130. Mattila OS, Strbian D, Saksi J, Pikkarainen TO, Rantanen V, Tatlisumak T, Lindsberg PJ, Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke 2011 42 3600 3605. doi: 10.1161/STROKEAHA.111.632224
131. Arac A, Grimbaldeston MA, Nepomuceno AR, Olayiwola O, Pereira MP, Nishiyama Y, Tsykin A, Goodall GJ, Schlecht U, Vogel H, Tsai M, Galli SJ, Bliss TM, Steinberg GK, Evidence that meningeal mast cells can worsen stroke pathology in mice. Am J Pathol 2014 184 2493 2504. doi: 10.1016/j.ajpath.2014.06.003
132. Choudhury GR, Ding S, Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol Dis 2016 85 234 244. doi: 10.1016/j.nbd.2015.05.003
133. Nedergaard M, Dirnagl U, Role of glial cells in cerebral ischemia. Glia 2005 50 281 286. doi: 10.1002/glia.20205
134. Benchenane K, López-Atalaya JP, Fernández-Monreal M, Touzani O, Vivien D, Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci 2004 27 155 160. doi: 10.1016/j.tins.2003.12.011
135. Li H, Zhang N, Lin HY, Yu Y, Cai QY, Ma L, Ding S, Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice. BMC Neurosci 2014 15 58. doi: 10.1186/1471-2202-15-58
136. Ding S, Wang T, Cui W, Haydon PG, Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo. Glia 2009 57 767 776. doi: 10.1002/glia.20804
137. Panickar KS, Norenberg MD, Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005 50 287 298. doi: 10.1002/glia.20181
138. McKimmie CS, Graham GJ, Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem Biophys Res Commun 2010 394 1006 1011. doi: 10.1016/j.bbrc.2010.03.111
139. Pekny M, Wilhelmsson U, Bogestål YR, Pekna M, The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007 82 95 111. doi: 10.1016/S0074-7742(07)82005-8
140. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK, A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009 137 47 59. doi: 10.1016/j.cell.2009.01.038
141. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A, Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003 198 725 736. doi: 10.1084/jem.20021098
142. Van De Beek D, Wijdicks EF, Vermeij FH, De Haan RJ, Prins JM, Spanjaard L, Dippel DW, Nederkoorn PJ, Preventive antibiotics for infections in acute stroke: A systematic review and meta-Analysis. Arch Neurol 2009 66 1076 1081
143. Koennecke HC, Belz W, Berfelde D, Berlin Stroke Register Investigators Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 2011 77 965 972. doi: 10.1212/WNL.0b013e31822dc795
144. Yilmaz G, Arumugam TV, Stokes KY, Granger DN, Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006 113 2105 2112. doi: 10.1161/CIRCULATIONAHA.105.593046
145. Brait VH, Arumugam TV, Drummond GR, Sobey CG, Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab 2012 32 598 611. doi: 10.1038/jcbfm.2012.6
146. Warrington R, Watson W, Kim HL, Antonetti FR, An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 2011 7 suppl 1 S1. doi: 10.1186/1710-1492-7-S1-S1
147. Bornstein NM, Aronovich B, Korczyn AD, Shavit S, Michaelson DM, Chapman J, Antibodies to brain antigens following stroke. Neurology 2001 56 529 530
148. Planas AM, Gómez-Choco M, Urra X, Gorina R, Caballero M, Chamorro Á Brain-derived antigens in lymphoid tissue of patients with acute stroke. J Immunol 2012 188 2156 2163. doi: 10.4049/jimmunol.1102289
149. Becker KJ, Sensitization and tolerization to brain antigens in stroke. Neuroscience 2009 158 1090 1097. doi: 10.1016/j.neuroscience.2008.07.027
150. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T, Austinat M, Nieswandt B, Wiendl H, Stoll G, Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010 115 3835 3842. doi: 10.1182/blood-2009-10-249078
151. Shichita T, Hasegawa E, Kimura A, Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med 2012 18 911 917. doi: 10.1038/nm.2749
152. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, Offner H, T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 2007 27 1798 1805. doi: 10.1038/sj.jcbfm.9600482
153. Chamorro Á Meisel A, Planas AM, Urra X, Van De Beek D, Veltkamp R, The immunology of acute stroke. Nat Rev Neurol 2012 8 401 410. doi: 10.1038/nrneurol.2012.98
154. Doyle KP, Quach LN, Solé M, Axtell RC, Nguyen TV, Soler-Llavina GJ, Jurado S, Han J, Steinman L, Longo FM, Schneider JA, Malenka RC, Buckwalter MS, B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci 2015 35 2133 2145. doi: 10.1523/JNEUROSCI.4098-14.2015
155. Adamski MG, Li Y, Wagner E, Yu H, Seales-Bailey C, Durkin H, Hao Q, Soper SA, Murphy M, Baird AE, Pre-existing hypertension dominates γδT cell reduction in human ischemic stroke. PLoS One 2014 9 e97755. doi: 10.1371/journal.pone.0097755
156. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, Iwakura Y, Yoshimura A, Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 2009 15 946 950. doi: 10.1038/nm.1999
157. Arumugam TV, Granger DN, Mattson MP, Stroke and T-cells. Neuromolecular Med 2005 7 229 242. doi: 10.1385/NMM:7:3:229
158. Hallenbeck J, How inflammation modulates central nervous system vessel activation and provides targets for intervention-A personal perspective. Ann N Y Acad Sci 2010 1207 1 7. doi: 10.1111/j.1749-6632.2010.05785.x
159. Mracsko E, Liesz A, Stojanovic A, Lou WP, Osswald M, Zhou W, Karcher S, Winkler F, Martin-Villalba A, Cerwenka A, Veltkamp R, Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke. J Neurosci 2014 34 16784 16795. doi: 10.1523/JNEUROSCI.1867-14.2014
160. Clarkson BD, Ling C, Shi Y, Harris MG, Rayasam A, Sun D, Salamat MS, Kuchroo V, Lambris JD, Sandor M, Fabry Z, T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice. J Exp Med 2014 211 595 604. doi: 10.1084/jem.20131377
161. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R, Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009 15 192 199. doi: 10.1038/nm.1927
162. Perdigoto AL, Chatenoud L, Bluestone JA, Herold KC, Inducing and Administering Tregs to Treat Human Disease. Front Immunol 2015 6 654. doi: 10.3389/fimmu.2015.00654
163. Xie L, Choudhury GR, Winters A, Yang SH, Jin K, Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol 2015 45 180 191. doi: 10.1002/eji.201444823
164. Brea D, Agulla J, Rodríguez-Yáñez M, Barral D, Ramos-Cabrer P, Campos F, Almeida A, Dávalos A, Castillo J, Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia. J Cell Mol Med 2014 18 1571 1579. doi: 10.1111/jcmm.12304
165. Xu X, Li M, Jiang Y, The paradox role of regulatory T cells in ischemic stroke. ScientificWorldJournal 2013 2013 174373. doi: 10.1155/2013/174373
166. Kleinschnitz C, Kraft P, Dreykluft A, Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013 121 679 691. doi: 10.1182/blood-2012-04-426734
167. Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G, Racchumi G, Ling L, Pamer EG, Iadecola C, Anrather J, Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat Med 2016 22 516 523. doi: 10.1038/nm.4068
168. Courties G, Herisson F, Sager HB, Heidt T, Ye Y, Wei Y, Sun Y, Severe N, Dutta P, Scharff J, Scadden DT, Weissleder R, Swirski FK, Moskowitz MA, Nahrendorf M, Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res 2015 116 407 417. doi: 10.1161/CIRCRESAHA.116.305207
169. Mestas J, Hughes CC, Of mice and not men: differences between mouse and human immunology. J Immunol 2004 172 2731 2738
170. Bacigaluppi M, Comi G, Hermann DM, Animal models of ischemic stroke. Part one: modeling risk factors. Open Neurol J 2010 4 26 33. doi: 10.2174/1874205X01004020026